TimothyRichardSmithMD
Neurosurgery • Boston, MAAssociate Professor, Neurosurgery, Harvard Medical School
Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
60 Fenwood Ave.
Department Of Neurosurgery
Boston, MA 02115Phone+1 617-525-3060Fax+1 312-695-0225
Education & Training
McGaw Medical Center of Northwestern UniversityResidency, Neurological Surgery, 2008 - 2014- McGaw Medical Center of Northwestern UniversityInternship, Transitional Year, 2007 - 2008
David Geffen School of Medicine at UCLAClass of 2007
Certifications & Licensure
ME State Medical License Current
CA State Medical License 2024 - 2026
RI State Medical License 2023 - 2026
CT State Medical License 2023 - 2025
MA State Medical License 2014 - 2025
NH State Medical License 2019 - 2025
VT State Medical License 2023 - 2024- American Board of Neurological Surgery Neurological Surgery
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsEthical considerations of neuro-oncology trial design in the era of precision medicineSaksham Gupta, Timothy R. Smith, Marike L. D. Broekman
Journal of Neuro-Oncology. 2017-05-29 - 75 citationsThirty-day readmission and reoperation after surgery for spinal tumors: a National Surgical Quality Improvement Program analysisAditya V. Karhade, Viren S. Vasudeva, Hormuzdiyar H. Dasenbrock, Yi Lu, William B. Gormley
Neurosurgical Focus. 2016-08-01 - 256 citationsMachine Learning and Neurosurgical Outcome Prediction: A Systematic ReviewJoeky T. Senders, Patrick Staples, Aditya V. Karhade, Mark M. Zaki, William B. Gormley
World Neurosurgery. 2018-01-01
Press Mentions
First-Line Treatment with Checkpoint Inhibitors Associated with Improved Overall Survival for Patients with Melanoma Brain MetastasesJuly 12th, 2018
RevBio Receives FDA Approval to Conduct a First-in-Human Clinical Trial for Its Regenerative Bone Adhesive for Cranial Flap FixationDecember 14th, 2023- FDA Greenlights RevBio’s Innovative Bone Glue Trial for Cranial SurgeryDecember 23rd, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
